Tinea Pedis clinical trials
The registry lists 73 studies for Tinea Pedis across more than 10 countries. 8 are recruiting or about to start. 66 of them are mainly about Tinea Pedis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27.
Get an email when these change. Save the Tinea Pedis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Taro Pharmaceuticals USA (8) · Merz North America, Inc. (4) · AmDerma (4) · DermBiont, Inc. (3) · Biolab Sanus Farmaceutica (2) · Padagis LLC (2) · Therapeutics, Inc. (2) · Tinea Pharmaceuticals (2)
What is being tested here
Drugs under test in Tinea Pedis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Apr 2027In Vitro Susceptibility of Dermatophytes to Terbinafine and Itraconazole: MIC Distributions and Elevated-MIC Isolates in Faisalabad, Pakistan · Dr. Amara Safdar
- Jun 2027A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes · Sinomune Pharmaceutical Co., Ltd
Who these studies take
Of the 5 Tinea Pedis studies recruiting now, 2 (40%) set no upper age limit and 3 (60%) stop at 75 or younger. 3 (60%) take children under 18. 1 (20%) are for women only and 0 (0%) for men only; 2 (40%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (20%) | 1 (20%) |
| 18 | 5 (100%) | 4 (80%) |
| 30 | 5 (100%) | 4 (80%) |
| 40 | 4 (80%) | 4 (80%) |
| 50 | 4 (80%) | 4 (80%) |
| 65 | 4 (80%) | 4 (80%) |
| 75 | 2 (40%) | 2 (40%) |
| 85 | 2 (40%) | 2 (40%) |
Across all 73 studies, recruiting or not: 36% stop at 75 or younger and 30% at 65; 36% take children; 3% are for women only and 4% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 73. Browse all 73 → or search them.
- In Vitro Susceptibility of Dermatophytes to Terbinafine and Itraconazole: MIC Distributions and Elevated-MIC Isolates in Faisalabad, PakistanRecruitingNCT078984751 country
- A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by DermatophytesRecruitingNCT07668999Phase 11 country
- Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea PedisRecruitingNCT07056660Not applicable1 country
- Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional StudyRecruitingNCT07245667Phase 21 country
- Sports Nutrition Assessment ProgramNot yet recruitingNCT071046691 country
- Effect of Kinesiotaping on Lower Limb Kinematics and Functional Related Outcomes Among Female Athletes With Chronic Lateral Ankle InstabilityNot yet recruitingNCT07054788Not applicable1 country
- Efficacy of Tropical Sertaconazole Nitrate 2% Vs Clotrimazole 1% for Tinea PedisNot yet recruitingNCT06869681Phase 4
- A Morphological Study in Volleyball Athletes With Cronic Ankle InstabilityRecruitingNCT057466631 country
- Advanced Footwear Technology in Federated AthletesCompletedNCT069191071 country
- A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea PedisCompletedNCT04152226Phase 21 country
- Effectiveness of Balance Training and Dynamic Neuromuscular Stabilization Training in Amateur Athletes with Chronic Ankle InstabilityCompletedNCT06296537Not applicable1 country
- Spread of Dermatophytes Among FamiliesCompletedNCT002334931 country
- Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea PedisCompletedNCT05363449Phase 11 country
- The Effect Of Plyometric Training On Balance And Proprioception In Different Branches AthletesCompletedNCT05754463Not applicable1 country
- A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea PedisStatus unknownNCT05493488Phase 21 country
- Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea PedisCompletedNCT03129321Phase 3
- A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea PedisCompletedNCT03897257Phase 22 countries
- Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea PedisCompletedNCT00804193Not applicable
- Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea PedisCompletedNCT00802672Phase 3
- Neurodynamics to Improve Jump Functionality in Trampoline Jump GymnastsWithdrawnNCT04289857Not applicable1 country
- A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. PedisTerminatedNCT04315051Phase 21 country
- A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.CompletedNCT04883593Early Phase 11 country
- Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry FeetCompletedNCT04265521Not applicable1 country
- Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea PedisTerminatedNCT02842021Phase 21 country
- Effects of the Elastic Taping on the Chronic Ankle InstabilityCompletedNCT04568577Not applicable1 country
- A Therapeutic Equivalence Study of Ketoconazole Cream 2%CompletedNCT04203342Phase 32 countries
- Non-inferiority Trial of Dapaconazole Versus KetoconazoleCompletedNCT03320486Phase 31 country
- Curcuma Extract Beneficial for Muscle DamageCompletedNCT04439981Not applicable1 country
- Study With Nåva Foot Cream in Patients With Tinea Pedis InterdigitalisCompletedNCT03676686Not applicable1 country
- Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea CrurisCompletedNCT02767271Phase 42 countries
- Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea CrurisCompletedNCT02394340Phase 41 country
- Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea PedisStatus unknownNCT02882438Phase 11 country
- Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's FootCompletedNCT02871011Phase 21 country
- Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea PedisCompletedNCT03824912Phase 33 countries
- SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDISStatus unknownNCT03999437Phase 21 country
- Cumulative Irritation TestCompletedNCT00781664Phase 11 country
- SB208 for the Treatment of Tinea PedisCompletedNCT02860052Phase 21 country
- Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea PedisCompletedNCT02335255Phase 1
- A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea PedisCompletedNCT01891305Phase 21 country
- Three-Arm Trial of Novel Treatment for Tinea PedisCompletedNCT03135912Phase 21 country
- A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)CompletedNCT00509275Phase 12 countries
- BE Study of Naftifine HCLCompletedNCT02633813Phase 32 countries
- Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea PedisCompletedNCT02132260Phase 1
- Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea PedisCompletedNCT01580878Phase 1
- Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea PedisWithdrawnNCT02606383Phase 31 country
- Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea PedisCompletedNCT01712360Phase 43 countries
- Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea PedisCompletedNCT02824926Phase 2
- Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs PlaceboCompletedNCT01013909Phase 21 country
- Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in PadarthamaraiCompletedNCT02238912Phase 21 country
- Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea PedisTerminatedNCT01119742Phase 1